Its reliable production is vital for manufacturing this non-ergot dopamine receptor agonist, available as a transdermal patch. 5-Methoxy-2-tetralone is a crucial pharmaceutical intermediate (building block) in the multi-step chemical synthesis of Rotigotine, a dopamine agonist drug used to treat Parkinson’s disease and restless legs syndrome, acting as a key precursor that undergoes further reactions (like reduction and amination) to form the final complex drug structure.
5-Methoxy-2-tetralone
| API Name | Rotigotine |
|---|---|
| CAS No | 32940-15-1 |
| Molecular Formula | C11H12O2 |
| Molecular Weight | 176.21 g/mol |
| Synonyms | 5-methoxy-3,4-dihydro-1H-naphthalen-2-one |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
Its reliable production is vital for manufacturing this non-ergot dopamine receptor agonist, available as a transdermal patch. 5-Methoxy-2-tetralone is a crucial pharmaceutical intermediate (building block) in the multi-step chemical synthesis of Rotigotine, a dopamine agonist drug used to treat Parkinson's disease and restless legs syndrome, acting as a key precursor that undergoes further reactions (like reduction and amination) to form the final complex drug structure.
The CAS number of 5-Methoxy-2-tetralone is 32940-15-1.
The molecular formula of 5-Methoxy-2-tetralone is C11H12O2.
The listed molecular weight of 5-Methoxy-2-tetralone is 176.21 g/mol.
5-Methoxy-2-tetralone is listed as being used in connection with the following API: Rotigotine.
The listed synonym or IUPAC name for 5-Methoxy-2-tetralone is 5-methoxy-3,4-dihydro-1H-naphthalen-2-one.